|
시장보고서
상품코드
2148330
헬스케어용 후각 진단 시장 : 기술별, 검체 유형별, 용도별, 최종사용자별, 지역별Healthcare Smell Diagnostics Market, By Technology, By Sample Type, By Application, By End User, By Geography |
||||||
헬스케어용 후각 진단 시장은 2026년에 2억 8,640만 달러 규모에 달할 것으로 추정되고 있으며, 2033년까지 6억 5,470만 달러에 달할 것으로 예상되고 있습니다. 2026-2033년에는 CAGR 12.5%로 성장할 것으로 전망되고 있습니다.
| 리포트 범위 | 리포트 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 2억 8,640만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 2026-2033년 예측 기간의 CAGR : | 12.50% | 2033년 시장 규모 예측 : | 6억 5,470만 달러 |
전 세계 헬스케어용 후각 진단 시장은 질병과 관련된 인체에서 방출되는 휘발성 유기 화합물(VOC)을 분석하는 신흥 진단 분야입니다. 전자 코, GC-MS, 센서 기반 VOC 분석, AI를 활용한 플랫폼 등의 기술을 통해 암, 호흡기 질환, 대사성 질환, 신경계 질환, 감염증 등의 질환 검출을 위한 연구가 진행되고 있습니다.
헬스케어 시스템이 비침습적, 조기, 그리고 개인 맞춤형 진단으로 전환되는 가운데, 전 세계 헬스케어용 후각 진단 시장이 주목받고 있습니다. 센서 기술, AI 및 VOC 프로파일링의 발전으로 인해 질환 특유의 분자 패턴을 탐지하는 능력이 향상되고 있으며, 호기 및 생체액을 이용한 신속한 진단 기법의 개발이 촉진되고 있습니다.
시장 역학
전 세계 헬스케어용 냄새 진단 시장은 특히 호흡기 질환, 대사성 질환, 신경계 질환, 감염증 및 암과 같은 질환에서 비침습적이고 조기 진단이 이루어지는 사례가 증가하고 있는 점에 힘입어 성장하고 있습니다. 인공지능과 기계학습을 전자 코 및 휘발성 유기 화합물(VOC) 분석 플랫폼과 통합함으로써, 실시간 분석을 통한 패턴 인식 및 진단 정확도의 향상이 기대되고 있습니다. 또한 휴대용 및 현장 진단(Point-of-Care)에 대한 관심이 높아짐에 따라 의료용 냄새 진단의 보급이 더욱 가속화될 것으로 예상됩니다.
그러나 헬스케어용 후각 진단 시장의 성장은 규제 표준화의 부재, VOC 측정에서의 재현성 부족, 높은 기술 비용, 그리고 많은 용도에서 임상적 타당성의 부족과 같은 요인들로 인해 제약을 받고 있습니다. 그럼에도 불구하고 새로운 진단 애플리케이션의 개발, AI 기반 플랫폼, 전략적 제휴, 그리고 아시아태평양, 라틴아메리카, 중동에서의 첨단 진단 기술 채택 확대에는 큰 기회가 존재합니다.
본 조사의 주요 특징
- 본 조사에서는 다양한 부문에 걸친 잠재적 수익 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스에 대해 해설하고 있습니다.
- 또한 본 조사에서는 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업이 채택하고 있는 경쟁 전략에 대한 중요 인사이트도 제공합니다.
- 본 조사에서는 다음 매개변수(기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략)를 바탕으로 전 세계 헬스케어 후각 진단 시장의 주요 업체들을 분석하고 있습니다.
- 이 보고서에서 얻은 인사이트를 바탕으로 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 대해 충분한 정보를 바탕으로 의사결정을 내릴 수 있게 됩니다.
- 본 ‘글로벌 헬스케어용 후각 진단 시장’ 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입 기업, 금융 분석가 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 전 세계 헬스케어 악취 진단 시장 분석에 활용되는 다양한 전략 매트릭스를 통해 원활하게 의사결정을 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 헬스케어용 후각 진단 시장 : 기술별, 2021-2033년
제5장 세계의 헬스케어용 후각 진단 시장 : 샘플 유형별, 2021-2033년
제6장 세계의 헬스케어용 후각 진단 시장 : 용도별, 2021-2033년
제7장 세계의 헬스케어용 후각 진단 시장 : 최종사용자별, 2021-2033년
제8장 세계의 헬스케어용 후각 진단 시장 : 지역별, 2021-2033년
제9장 경쟁 구도
제10장 애널리스트의 제안
제11장 참고 문헌 및 조사 방법
KSA 26.10.19Healthcare Smell Diagnostics Market is estimated to be valued at USD 286.4 Mn in 2026 and is expected to reach USD 654.7 Mn by 2033, growing at a compound annual growth rate (CAGR) of 12.5% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 286.4 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 12.50% | 2033 Value Projection: | USD 654.7 Mn |
The global healthcare smell diagnostics market is an emerging diagnostic field that analyzes volatile organic compounds (VOCs) emitted by the human body that are associated with diseases. Technologies such as electronic nose, GC-MS, sensor-based VOC analysis and AI-enabled platforms are being explored for detection of diseases like cancer, respiratory diseases, metabolic disorders, neurological diseases and infections.
The global healthcare smell diagnostics market is gaining attention as healthcare systems are moving toward non-invasive, early and personalized diagnostics. Advances in sensor technology, AI and VOC profiling are enhancing the ability to detect disease-specific molecular patterns in support of the development of rapid breath- and biofluid-based diagnostic approaches.
Market Dynamics
The global healthcare smell diagnostics market is driven by the increasing incidence of disease diagnosis through non-invasive and early diagnosis, especially for respiratory, metabolic, neurological, infectious and cancerous diseases. The integration of artificial intelligence and machine learning along with electronic nose and volatile organic compound analysis platforms is expected to improve pattern recognition and diagnostic accuracy with real-time analysis. The increasing interest for portable and point of care diagnostics is expected to further propel the adoption of healthcare smell diagnostics.
However, the growth of healthcare smell diagnostics market is limited by factors such as absence of regulatory standardization, lack of reproducibility in VOC measurements, high cost of technology, and lack of clinical validation for many applications. Nevertheless, significant opportunities exist in the development of novel diagnostic applications, AI-based platforms, strategic collaborations, and increasing adoption of advanced diagnostics in Asia Pacific, Latin America, and the Middle East.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global healthcare smell diagnostics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Owlstone Medical Limited, Breathomix B.V., Breath Diagnostics, Inc., eNose Company B.V., Ainos, Inc., The eNose Company, Mistral S.r.l., Nanose Medical Ltd., AIREX Inc., and Ancon Medical Limited
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global healthcare smell diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global healthcare smell diagnostics market
Market Segmentation
- Technology Insights (Revenue, USD Mn, 2021 - 2033)
- Electronic Nose (E-Nose)
- Gas Chromatography-Mass Spectrometry (GC-MS)
- Sensor-Based VOC Analysis
- Mass Spectrometry-Based Analysis
- Others
- Sample Type Insights (Revenue, USD Mn, 2021 - 2033)
- Exhaled Breath
- Blood
- Urine
- Saliva
- Others
- Application Insights (Revenue, USD Mn, 2021 - 2033)
- Cancer Detection
- Respiratory Disease Detection
- Infectious Disease Detection
- Metabolic Disease Detection
- Gastrointestinal and Liver Disease Detection
- Neurological Disease Detection
- Others
- End User Insights (Revenue, USD Mn, 2021 - 2033)
- Hospitals and Clinics
- Diagnostic Laboratories
- Research Institutes
- Pharmaceutical and Biotechnology Companies
- Others
- Regional Insights (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Owlstone Medical Limited
- Breathomix B.V.
- Breath Diagnostics, Inc.
- eNose Company B.V.
- Ainos, Inc.
- The eNose Company
- Mistral S.r.l.
- Nanose Medical Ltd.
- AIREX Inc.
- Ancon Medical Limited
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Healthcare Smell Diagnostics Market, By Technology
- Global Healthcare Smell Diagnostics Market, By Sample Type
- Global Healthcare Smell Diagnostics Market, By Application
- Global Healthcare Smell Diagnostics Market, By End User
- Global Healthcare Smell Diagnostics Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Technology Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Market Opportunities
- Industry Trends
4. Global Healthcare Smell Diagnostics Market, By Technology, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Electronic Nose (E-Nose)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Gas Chromatography-Mass Spectrometry (GC-MS)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Sensor-Based VOC Analysis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Mass Spectrometry-Based Analysis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
5. Global Healthcare Smell Diagnostics Market, By Sample Type, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Exhaled Breath
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Blood
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Urine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Saliva
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
6. Global Healthcare Smell Diagnostics Market, By Application, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Cancer Detection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Respiratory Disease Detection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Infectious Disease Detection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Metabolic Disease Detection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Gastrointestinal and Liver Disease Detection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Neurological Disease Detection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
7. Global Healthcare Smell Diagnostics Market, By End User, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospitals and Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Pharmaceutical and Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
8. Global Healthcare Smell Diagnostics Market, By Region, 2021 - 2033, Value (USD Mn)
- Introduction
- Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User,2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User,2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User,2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
- South Africa
- North Africa
- Central Africa
9. Competitive Landscape
- Owlstone Medical Limited
- Company Highlights
- Technology Portfolio
- Key Developments
- Financial Performance
- Strategies
- Breathomix B.V.
- Company Highlights
- Technology Portfolio
- Key Developments
- Financial Performance
- Strategies
- Breath Diagnostics, Inc.
- Company Highlights
- Technology Portfolio
- Key Developments
- Financial Performance
- Strategies
- eNose Company B.V.
- Company Highlights
- Technology Portfolio
- Key Developments
- Financial Performance
- Strategies
- Ainos, Inc.
- Company Highlights
- Technology Portfolio
- Key Developments
- Financial Performance
- Strategies
- The eNose Company
- Company Highlights
- Technology Portfolio
- Key Developments
- Financial Performance
- Strategies
- Mistral S.r.l.
- Company Highlights
- Technology Portfolio
- Key Developments
- Financial Performance
- Strategies
- Nanose Medical Ltd.
- Company Highlights
- Technology Portfolio
- Key Developments
- Financial Performance
- Strategies
- AIREX Inc.
- Company Highlights
- Technology Portfolio
- Key Developments
- Financial Performance
- Strategies
- Ancon Medical Limited
- Company Highlights
- Technology Portfolio
- Key Developments
- Financial Performance
- Strategies
10. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
11. References and Research Methodology
- References
- Research Methodology
- About us
